Strides gains USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg
Strides is eligible for 180 days of Competitive Generic Therapy (CGT) exclusivity for Theophylline Extended-Release Tablets, 300…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Theophylline Extended-Release Tablets
Glenmark gets US FDA approval for Theophylline ER Tablets, 300 mg and 450 mg
Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity on the 450 mg